Skip to main content
Log in

Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study

  • Articles
  • Published:
Lipids

Abstract

The objective of this work was to assess the therapeutic efficacy and to lerability of intravenously applied n-3-PUFA in patients with active rheumatoid arthritis (RA). Thirty-four patients with active RA [identified as having a DAS28 (disease activity score including a 28 joint count) >4.0] were enrolled into this 5-wk open pilot study (one group design). From the time of screening (visit 0, or V0), background therapy had to remain unchanged. Patients received 2 mL/kg(=0.1–0.2 g fish oil/kg) fish oil emulsion intravenously on 7 consecutive days (Visit 1–Visit 2, or V1–V2) in addition to their background therapy. A decrease of the DAS28>0.6 at day 8 (Visit 2) was the primary efficacy measure. Moreover, the DAS28 at day 35 (Visit 3, or V3), the modified Health Assessment Questionnaire, the American College of Rheumatology (ACR) response criteria (V2, V3) and the Short Form-36 (V3) were assessed. Thirty-three patients completed the trial. The mean DAS28 at V1 was 5.45; at V2, 4.51 (P<.001 V1–V2) and at V3, 4.73 (P<.001 V1–V3; V2–V3, not significantly different). Of the 34 patients, 56% achieved a reduction of the DAS28>0.6 at V2 (mean 1.52); 27%>1.2. At V3, 41% of the patients showed a DAS28 reduction >0.6 (mean 1.06), and 36%>1.2. ACR 20 and 50% responses at V2 were seen in 29 and 12% of patients, respectively; at V3, the comparable values were 18 and 9%, respectively. Overall tolerability was excellent. Intravenous application of n-3-PUFA (as an add-on therapy) was considerably well tolerated and led to improvement of the disease activity status in a reasonable number of RA patients. Future trials are warranted to answer whether the intravenous application of n-3-PUFA constitutes a therapeutic option in RA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ACR:

American College of Rheumatology

BMI:

body mass index

CRP:

C-reactive protein

DAS28:

disease activity score including a 28-joint count

DMARD:

disease-modifying antirheumatic drug(s)

ESR:

erythrocyte sedimentation rate

EULAR:

European League Against Rheumatism

EULARC:

EULAR response criteria

ITT:

intent-to-treat

M-HAQ:

modified health assessment questionnaire

NS:

not significantly different

NSAID:

nonsteroidal antirheumatic drug(s)

RA:

rheumatoid arthritis

RF:

IgM-rheumatoid factor

SF-36:

Medical Outcomes Study Short Form 36

SJC:

swollen joint count

TJC:

tender joint count

V0:

screening visit

V1:

study entry visit

V2:

visit after 1 wk

V3:

final visit (4 wk after application of PUFA)

VAS:

visual analog scale

VAS-GH:

visual analog scale of patient's general health

VAS pain:

visual analog scale of patient's pain

VAS ph:

visual analog scale of physician's global assessment

References

  1. Shapiro, J.A., Koepsell, T., Voight, L.F., Dugowson, C.E., Kestin, M., and Nelson, J.L. (1996) Diet and Rheumatoid Arthritis in Women: A Possible Protective Effect of Fish Consumption. Epidemiology 7, 256–263.

    Article  PubMed  CAS  Google Scholar 

  2. Linos, A., Kaklamanis, E., Kontomerkos, A., Koumantaki, Y., Gazi, S., Vaiopoulos, G., Tsokos, G.C., and Kaklamanis, P. (1991) The Effect of Olive Oil and Fish Consumption on Rheumatoid Arthritis: A Case Control Study. Scand. J. Rheumatol. 20, 419–426.

    PubMed  CAS  Google Scholar 

  3. Linos, A., Kaklamani, V.G., Kaklamani, E., Koumantaki, Y., Giziaki, E., Papazoglou, S., and Mantzoros, C.S. (1999) Dietary Factors in Relation to Rheumatoid Arthritis: A Role for Olive Oil and Cooked Vegetables? Am. J. Clin. Nutr. 70, 1077–1082.

    PubMed  CAS  Google Scholar 

  4. Recht, L., Helin, P., Rasmussen, J.O., Jacobsen, J., Lithman, T., and Scherstén, B. (1990) Hand Handicap and Rheumatoid Arthritis in a Fish-Eating Society (the Faroe Islands). J. Intern. Med. 227, 49–55.

    Article  PubMed  CAS  Google Scholar 

  5. Drosos, A.A., Alamanos, I., Voulgari, P.V., Psychos, D.N., Katsaraki, A., Papadopoulos, I., Dimou, G., and Siozos, C. (1997) Epidemiology of Adult Rheumatoid Arthritis in Northwest Greece 1987–1995. J. Rheumatol. 24, 2129–2133.

    PubMed  CAS  Google Scholar 

  6. Calder, P.C. (2002) Dietary Modification of Inflammation with Lipids, Proc. Nutr. Soc. 6, 345–358.

    Google Scholar 

  7. Kremer, J.M., Lawrence, D.A., Jubiz, W., DiGiacomo, R., Rynes, R., Bartholomew, L.E., and Sherman, M. (1990) Dietary Fish Oil and Olive Oil Supplementation in Patients with Rheumatoid Arthritis. Clinical and Immunologic Effects, Arthritis Rheum. 33, 810–820.

    Article  PubMed  CAS  Google Scholar 

  8. Trichopoulou, A., and Vasilopoulou, E. (2000) Mediterranean Diet and Longevity, Br. J. Nutr. (Suppl. 2), 205–209.

    Article  Google Scholar 

  9. de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J.-L., Guidollet, J., Touboul, P., and Delaye, J. (1994) Mediterranean α-Linolenic Acid Rich Diet in Secondary Prevention of Coronary Heart Disease. Lancet 343, 1454–1459.

    Article  PubMed  Google Scholar 

  10. Cleland, L.G., and James, M.J. (2000) Fish Oil and Rheumatoid Arthritis: Antiinflammatory and Collateral Health Benefits. J. Rheumatol. 27, 2305–2307.

    PubMed  CAS  Google Scholar 

  11. Arnett, F.C., Edwarthy, S.M., Bloch, D.A., McShane, D.J., Fries, D.J., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., et al. (1988) The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum. 31, 315–324.

    Article  PubMed  CAS  Google Scholar 

  12. Prevoo, M.L., van't Hof, M.A., Kuper, H.H., van Leeuwen, M.A., van de Putte, L.B., and van Riel, P.L. (1995) Modified Disease Activity Scores That Include Twenty-Eight-Joint Counts. Development and Validation in a Prospective Longitudinal Study of Patients with Rheumatoid Arthritis. Arthritis Rheum. 38, 44–48.

    Article  PubMed  CAS  Google Scholar 

  13. Van Gestel, A.M., and Prevoo, M.L., van't Hof, M.A., van Rijswijk M.H., van de Putte L.B., van Riel, P.L.C.M., (1996) Development and Validation of the European League Against Rheumatism Response Criteria for Rheumatoid Arthritis. Comparison with the Preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 39, 34–40.

    Article  PubMed  Google Scholar 

  14. Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D.E., Goldsmith, C., Katz, L.M., Lightfoot, R., Jr. Paulus, H., Strand, V., et al. (1995) American College of Rheumatology. Preliminary Definition of Improvement in Rheumatoid Arthritis. Arthritis Rheum. 38, 727–735.

    Article  PubMed  CAS  Google Scholar 

  15. Pincus, T., Summey, J.A., Soraci, S.A., Jr., Wallston, K.A., and Hummon, N.P. (1983) Assessment of Patient Satisfaction in Activities of Daily Living Using a Modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 26, 1346–1353.

    Article  PubMed  CAS  Google Scholar 

  16. Garratt, A.M., Ruta, D.A., Abdalla, M.I., Buckingham, J.K., and Russell, I.T. (1993) The SF-36 Health Survey Questionnaire: An Outcome Measure Suitable for Routine Use Within the NHS? Br. Med. J. 306, 1440–1444.

    Article  CAS  Google Scholar 

  17. Cleland, L.G., James, M.J., and Proudman, S.M. (2003) The Role of Fish Oils in the Treatment of Rheumatoid Arthritis, Drugs 63, 845–853.

    Article  PubMed  CAS  Google Scholar 

  18. Steinmetz, A. (2003) Treatment of Diabetic Dyslipoproteinemia, Exp. Clin. Endocrinol. Diabetes 111, 239–245.

    Article  PubMed  CAS  Google Scholar 

  19. Adam, O., Beringer, C., Kless, T., Lemmen, C., Adam, A., Wiseman, M., Adam, P., Klimmek, R., and Forth, W. (2003) Anti-inflammatory Effects of a Low Arachidonic Acid Diet and Fish Oil in Patients with Rheumatoid Arthritis. Rheumatol. Int. 23, 27–36.

    PubMed  CAS  Google Scholar 

  20. Sköldstam, L., Hagfors, L., and Johansson, G. (2003) An Experimental Study of a Mediterranean Diet Intervention for Patients with Rheumatoid Arthritis. Ann. Rheum. Dis. 62, 208–214.

    Article  PubMed  Google Scholar 

  21. Leeb, B.F., Andel, I., Leder, S., Leeb, B.A., and Rintelen, B. (2005) The Patient's Perspective and Rheumatoid Arthritis Disease Activity Indexes. Rheumatology (Oxford) 44, 360–365, 569.

    Article  CAS  Google Scholar 

  22. Kingsley, G.H., Khoshaba, B., Smith, C.M., Choy, E.H., and Scott, D.L. (2005) Are Clinical Trials in Rheumatoid Arthritis Generalizable to Routine Practice? A Re-evaluation of Trial Entry Criteria. Rheumatology (Oxford) 44, 629–632.

    Article  CAS  Google Scholar 

  23. Maini, R., St. Clair, E.W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) Versus Placebo in Rheumatoid Arthritis Patients Receiving Concomitant Methotrexate: A Randomised Phase III Trial, Lancet 354, 1932–1939.

    Article  PubMed  CAS  Google Scholar 

  24. Bresnihan, B., Alvaro-Gracia, J.M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) Treatment of Rheumatoid Arthritis with Recombinant Human Interleukin-1 Receptor Antagonist, Arthritis Rheum, 41, 2196–2204.

    Article  PubMed  CAS  Google Scholar 

  25. James, M.J., and Cleland, L.G. (1997) Dietary n-3 Fatty Acids and Therapy for Rheumatoid Arthritis. Semin. Arthritis Rheum. 27, 85–97.

    Article  PubMed  CAS  Google Scholar 

  26. Greenwood, M.C., Doyle, D.V., and Ensor, M. (2001) Does the Stanford Health Assessment Questionnaire Have Potential as a Monitoring Tool for Subjects with Rheumatoid Arthritis? Ann. Rheum. Dis. 60, 344–348.

    Article  PubMed  CAS  Google Scholar 

  27. Volker, D., Fitzgerald, P., Major, G., and Garg, M. (2000) Efficacy of Fish Oil Concentrate in the Treatment of Rheumatoid Arthritis, J. Rheumatol. 27, 2343–2346.

    PubMed  CAS  Google Scholar 

  28. Kremer, J.M., Lawrence, D.A., Petrillo, G.F., Litts, L.L., Mullaly, P.M., Rynes, R.I., Stocker, R.P., Parhami, N., Greenstein, N.S., Fuchs, B.R., et al. (1995) Effects of High-Dose Fish Oil on Rheumatoid Arthritis After Stopping Nonsteroidal Antiinflammatory Drugs. Clinical and Immune Correlates, Arthritis Rheum. 38, 1107–1114

    Article  PubMed  CAS  Google Scholar 

  29. Wolfram, G. (2003) Dietary Fatty Acids and Coronary Heart Disease, Eur. J. Med. Res. 8, 321–324.

    PubMed  CAS  Google Scholar 

  30. Maini, R.N., Breedveld, F.C., Kalden, J.R., Smolen, J.S., Davis, D., Macfarlane, J.D., Antoni, C., Leeb, B., Elliott, M.J., Woody, J.N. et al. (1998) Therapeutic Efficacy of Multiple Intravenous Infusions of Anti-tumor Necrosis Factor Alpha Monoclonal Antibody Combined with Low-Dose Weekly Methotrexate in Rheumatoid Arthritis, Arthritis Rheum. 41, 1552–1563.

    Article  PubMed  CAS  Google Scholar 

  31. O'Dell, J.R. (2004) Therapeutic Strategies for Rheumatoid Arthritis, N. Engl. J. Med. 350, 2591–2602.

    Article  PubMed  Google Scholar 

  32. Fassl, C., Sautner, J., Rintelen, B., and Leeb, B.F. (2005) Intravenous Application of Omega-3 Fatty Acids in a Patient with Active Spondylarthropathy-A Case Report, Clin. Rheumatol., October 12 [Epub ahead of print].

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Burkhard F. Leeb.

About this article

Cite this article

Leeb, B.F., Sautner, J., Andel, I. et al. Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study. Lipids 41, 29–34 (2006). https://doi.org/10.1007/11745-006-5066-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/11745-006-5066-x

Keywords

Navigation